GB201808101D0 - Dosage regime - Google Patents

Dosage regime

Info

Publication number
GB201808101D0
GB201808101D0 GBGB1808101.8A GB201808101A GB201808101D0 GB 201808101 D0 GB201808101 D0 GB 201808101D0 GB 201808101 A GB201808101 A GB 201808101A GB 201808101 D0 GB201808101 D0 GB 201808101D0
Authority
GB
United Kingdom
Prior art keywords
dosage regime
regime
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1808101.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune Ltd
Original Assignee
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedImmune Ltd filed Critical MedImmune Ltd
Priority to GBGB1808101.8A priority Critical patent/GB201808101D0/en
Publication of GB201808101D0 publication Critical patent/GB201808101D0/en
Ceased legal-status Critical Current

Links

GBGB1808101.8A 2018-05-18 2018-05-18 Dosage regime Ceased GB201808101D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1808101.8A GB201808101D0 (en) 2018-05-18 2018-05-18 Dosage regime

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1808101.8A GB201808101D0 (en) 2018-05-18 2018-05-18 Dosage regime

Publications (1)

Publication Number Publication Date
GB201808101D0 true GB201808101D0 (en) 2018-07-04

Family

ID=62723338

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1808101.8A Ceased GB201808101D0 (en) 2018-05-18 2018-05-18 Dosage regime

Country Status (1)

Country Link
GB (1) GB201808101D0 (en)

Similar Documents

Publication Publication Date Title
IL276232A (en) Pharmaceutical compounds
GB2569961B (en) Pharmaceutical
GB2572126B (en) Pharmaceutical
GB2572125B (en) Pharmaceutical
GB201810245D0 (en) Pharmaceutical compounds
GB201713653D0 (en) Dosage regimen
IL275708A (en) G1t38 superior dosage regimes
GB201810239D0 (en) Pharmaceutical compounds
GB201819961D0 (en) Pharmaceutical compounds
IL283900A (en) Pharmaceutical combinations
PL3484451T3 (en) Dosage form
GB201819960D0 (en) Pharmaceutical compounds
IL277334A (en) Pharmaceutical combinations
IL279334A (en) Pharmaceutical combinations
GB201801562D0 (en) Pharmaceutical compounds
GB201800378D0 (en) Pharmaceutical compounds
IL269169A (en) Novel dosage form
GB201816369D0 (en) Pharmaceutical compounds
IL283273A (en) Pharmaceutical methods
GB201607548D0 (en) Solid dosage form
GB201812049D0 (en) Pesticidal dosage form
GB201808473D0 (en) Dosage regime
GB201808507D0 (en) Dosage Regime
GB201808101D0 (en) Dosage regime
GB201803298D0 (en) Dosage regime

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)